Clinical and pathological correlation of P53 expression in oral cancers

Autor: Ravishankar, Bellala, Madhavi, Bellala Venkata, Kalagara, Akash, Bodepudi, Srija, Harnadh, Sriharsha, Bindu, P.Josephine, Pydi, Venkateswar Rao, Raj, Bellala Prithvi, Nitya, Gopireddy, Rishik, Bellala

Publikováno v: In Pathology - Research and Practice January 2024 253

Literature review on targeted therapies in management of solid tumours

Autor: null Madhavi Venkata Bellala, null Srikanth Dikkala, null Tulika Tyagi, null Prithviraj Bellala, null Rishik Bellala, null Ravishankar Bellala

Publikováno v: International Journal of Scientific Research Updates. 3:010-021

Purpose: To depict the emergence of targeted therapies that have led to distinguished breakthrough in the management of cancer. Methods: The literature was systematically reviewed, based on their evolution and their use with understanding on the adve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ad48995badb538076f578dccae2aef8c
https://doi.org/10.53430/ijsru.2022.3.1.0021

Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis

Autor: Chaiyut Charoentum, Fernanda Rafaela Garcia, Andric Zoran, Luis Figuero Pérez, Bojan Zaric, Felicitas Bullo, Igor Bondarenko, Ravishankar Bellala, Elena Poddubskaya, Serhii Shevnia, D. Trukhin

Publikováno v: Journal of Clinical Oncology. 39:e15003-e15003

e15003 Background: Stella Trial is a phase III, multinational, double-blind and randomized study to confirm clinical similarity between MB02 and EU-bevacizumab in patients with stage IIIB/IV no squamous NSCLC. 627 subjects with newly diagnosed or rec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4ba7f3a00dc2a06790674b528dbc89c6
https://doi.org/10.1200/jco.2021.39.15_suppl.e15003

Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck Cancer: A Multicenter, Randomized, Double-Blind, Phase III Trial.

Autor: Prabhash K; Medical Oncology, Tata Memorial Hospital, Mumbai, India., Deshmukh C; Deenanath Mangeshkar Hospital & Research Center, Pune, India., Malhotra H; Medical Oncology, Sriram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, India., Sharma A; Medical Oncology, All India Institute of Medical Sciences, New Delhi, India., Jain M; KEM Hospital and Research Center, Pune, India., Dhamne N; Kolhapur Cancer Center, Kolhapur, India., Nagarakar R; HCG Manavata Cancer Center, Nashik, India., Ganesan P; Department of Oncology, Jawaharlal Institute of Postgraduate Medical Education, Puducherry, India., Mahobia VK; Government Medical College, Nagpur, India., Das CK; Department of Radiotherapy and Oncology, Regional Cancer Center, PGIMER, Chandigarh, India., Kumar R; Department of Radiation Oncology, Regional Cancer Center, Trivandrum, India., Shivanna PS; Mysore Medical College and Research Institute and K.R. Hospital, Mysore, India., Avaronnan MP; Malabar Cancer Center, Kannur, India., Chaithanya PK; MNJ Institute of Oncology and Regional Cancer Center, Hyderabad, India., Chaudhary V; Medical Oncology, RST Regional Cancer Hospital and Research Center, Nagpur, India., Singh K; Medical Oncology, RST Regional Cancer Hospital and Research Center, Nagpur, India., Aagre S; Ayush Hospital, Mumbai, India., Ravishankar B; Omega Hospital Chinna Gadhili, Visakhapatnam, India., Mehta D; Nirmal Hospital, Surat, India., Shilpa K; Department of Medical Oncology, Andhra Medical College/King George Hospital, Visakhapatnam, India., Maniar V; MOC Vile Parle, Mumbai, India., Chatterjee K; Health Point Hospital, Kolkata, India., Majumdar SD; Head of Department, Radiotherapy, All India Institute of Medical Sciences, Bhubaneshwar, India., Dana R; Head of Department, Radiotherapy, SMS Medical College and Hospital, Jaipur, India., Noronha V; Tata Memorial Hospital, Mumbai, India., Menon N; Medical Oncology, Tata Memorial Hospital, Mumbai, India., Sharma A; Medical Department, Alkem Laboratories Limited, Mumbai, India., Pawar R; Medical Department, Alkem Laboratories Limited, Mumbai, India., Shahavi V; Medical Department, Alkem Laboratories Limited, Mumbai, India., Yadav R; Medical Department, Alkem Laboratories Limited, Mumbai, India., Aiwale A; Medical Department, Alkem Laboratories Limited, Mumbai, India.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2024 Nov; Vol. 10, pp. e2400059. Date of Electronic Publication: 2024 Nov 14.